Sentences with phrase «drug prices while»

Trump lashed out quickly at Frazier on Twitter after the announcement, accusing the drugmaker of being «a leader in higher & higher drug prices while at the same time taking jobs out of the U.S.»

The president followed up later in the day, tweeting that Merck «is a leader in higher & higher drug prices while at the same time taking jobs out of the U.S. Bring jobs back & LOWER PRICES!»

Not exact matches

By contrast, while the cost of older, branded pharmaceuticals continue to rise and contribute to increased spending, when discounting is considered, prices of these drugs increased, on average, 2.8 % in 2015, the lowest growth rate in years.

Mark Merritt, CEO of the Pharmaceutical Care Management Association (PCMA), a trade group representing the 10 largest traditional PBMs, says that while «drug prices have gone up more than we'd like» over the years, his members have saved employers 25 %.

While we wait to see how much Newfoundland is able to extract, note that Ottawa offered two other similarly vague compensation deals to get CETA through: One on drug prices, tied to a lengthening of patent protection, and another to the dairy industry as protection against an increase in duty - free European cheese.

The company has responded with statements saying that it's not as dependent on drug price increases as critics have claimed; it has also pointed out that while attention has focused on changes in list prices for drugs, those prices don't reflect the actual cost for insurers, governments and other group purchasers, which typically receive discounts that aren't publicly disclosed.

Tree — who said the policy change restored a price support for growers by reintroducing a «federal risk premium» — told Business Insider that while consumers in states were marijuana was legal were probably used to a high - quality and tested product, he suspected cracking down on legal marijuana production and sales would incentivize trafficking of lower - quality marijuana to states where the drug is still illegal.

While some remain defiant and plan to continue their work, one party in particular stands to benefit if the new policy restricts legal sales and pushes prices up — Mexican drug traffickers who see marijuana as a kind of cash crop.

While several of the present CEOs responded optimistically to the meeting — praising the deregulation and tax reduction components in particular — and many of their companies» shares rose on hopes that Trump won't be as antagonistic toward drug makers as his recent comments that they're «getting away with murder» on prices would suggest, don't count on the wish list to come true.

Both companies have since rolled back their price increases, and experts say that while drug prices will continue to rise the practice of hiking prices purely for profit may be on the wane.

He's endorsed policies like direct drug price negotiation in Medicare (usually a Democratic wish list item that's despised by drug makers) while simultaneously promising to slash other regulations on the biopharma industry; he famously promised «insurance for everybody» yet ostensibly supports benefit cuts and a rollback of the Medicaid expansion, which has covered millions of the poorest Americans.

Slavitt's letter said that while CMS notified drugmakers about the correct classification of their products, «it is the manufacturer's responsibility to report accurate product and pricing data to the Medicaid Drug Rebate Program.»

While exorbitant drug price hikes by Martin Shkreli's Turing Pharmaceuticals and Valeant have sparked outrage in Washington and tanked the stock prices of much of the pharmaceutical sector in the last six months, there's growing evidence that the controversy may be more smoke than fire.

And despite the fact that Mylan raised EpiPen prices roughly 30 % in 2015 while prescription volume also grew 7 %, the company's revenue on the drug actually fell slightly, as the other players took even bigger cuts, according to Raffat.

While some responders had particular axes to grind (it's true that U.S. drug prices are radically higher than elsewhere in the world, for instance, and maybe a gamma ray burst could destroy earth, but those aren't really things you can act on tomorrow), many more offered healthful reality checks that most of us could benefit from, including:

While Marathon asserts that its list price is reasonable for treating such a devastating condition, it's unclear whether or not insurance companies will be eager to cover the drug for Duchenne patients.

While the drug maker has responded to the massive backlash over its extravagant price increase on the device by boosting its patient assistance programs and introducing an authorized generic EpiPen version at half the cost, CVS» topline price will still be significantly cheaper.

After years of buying up companies then raising the prices of their drugs — a strategy that rapidly amplified Valeant's revenue and stock price — Valeant is now struggling to grow by other means, while dealing with the consequences of its previous actions.

Congress remains at an impasse over the future of the Affordable Care Act, while employers and consumers are struggling under the weight of rising medical costs, including the soaring price of prescription drugs.

HERERA: An expensive cholesterol drug is getting a price cut and while that may sound like a good thing the lower price wo n`t necessarily be available to everyone who wants the medicine.

«While we understand a steady, rational increase in prices, it is the sudden, unfounded price explosions in select older drugs that hinder us in caring for patients,» Fogel told the committee.

Wall Street «s reaction to the deal was mixed, with some fearing a price war means the drug makers have lost ground to the insurers, while others suggested it might be just what «s needed to turn sales of the medicine around.

While high price tags are common for rare disease drugs, Emflaza is part of a class of drugs called corticosteroids that are used for DMD in other parts of the world.

While Mr. Berman accused the benefit managers of being complicit, he said the lawsuit focused on the drug makers because «they are playing the game, and they are the ones who publish the list price.»

While Donald Trump's tweets can shake up pharmaceutical stocks, history suggests that investors have little to fear from the president's drug pricing rhetoric.

«While drugs are free in public facilities, the cost of transport often exceeds the price we charge, so because we deliver to the client's doorstep the model technically «cheaper than free».

While most of the attention on pharmaceutical prices has been on new drugs for diseases like cancer, hepatitis C and high cholesterol, there is also growing concern about huge price increases on older drugs, some of them generic, that have long been mainstays of treatment.

Blueprint Medicines (BPMC)- The current $ 3.75 billion valuation compares favorably to $ 2 billion peak sales potential of two lead drug candidates, while their solid cash position after the December secondary offering and their deep pipeline provide adequate cushion to the current share price.

As with any such intentions, the actual rules are gamed, resulting in excessive prices in the US (especially for so - called orphan drugs) while claims that this system is necessary for further development of new drugs are not empirically supported.

Price segregation allows vital drugs to be provided at cost (or closer to it) for low - income nations, while American customers pay high enough prices to fund research and development of new medications.

While about 33 % of beneficiaries are part of this system where insurance can negotiate, known as «Medicare Advantage», most Medicare beneficiaries receive benefits directly from the government agency involved which pays 106 % of the «standard price» for prescription drugs without negotiation.

A pharmaceutical research group is launching a campaign against Cuomo's proposal to control the price of prescription drugs, saying it will do nothing to improve patient access to prescriptions while threatening research and development.

After controlling for other factors, a generic drug in the highest marketing competition group was expected to see a decrease of 32 percent in price over the study period, while a generic drug in the lowest market competition was expected to see a price increase of 47 percent over the same period.

But while the deals may be beneficial to some extent, in that they might save courts and administrative bodies, such as patent offices, time and effort, they allow branded drug firms to charge monopoly prices and in a typical deal there may be a two to three year delay in a cheaper version becoming available.

Doctors often cite the high price of a prescription drug as a reason they don't prescribe it, while patients similarly say that cost is a main reason they quit taking a drug.

They found that, at current drug prices, treating half of those who are currently infected and are aware of their status but have not yet been treated would cost about $ 53 billion over five years, while treating these patients only at stages three and four would cost $ 30 billion.

These inactive pills can then be sold at a fraction of the price of the real drug while still making a profit.

At some drug stores, the price for a three - month supply of the lowest starting dose (5 mg) of bisoprolol fumarate is about $ 140, while another beta - blocker, atenolol, costs only around $ 20 for the lowest starting dose (25 mg)..

While it doesn't work for everyone, «it is low risk and minimally invasive, unlike surgery, and it will not harm your organs, like long - term drug use,» Price said.

While effective in many cases, these drugs unfortunately come with a price: in some women lithium may lower thyroid levels causing rapid cycling of depressive - maniac cycles; valporic acid may increase the level of testosterone in young women leading to disruption of menstrual cycles and excess body hair.

That's how it maintains the low, low prices customers love, while driving booksellers out of business and framing publishers as greedy villains — even though books are the * only * product we sell, whereas books are just the gateway drug Amazon uses to lure customers through the door.

While the stock is doing a bit better in the past month due to some positive news they've received in regards to a trial drug approval, it only surpassed the price at which I bought it, this week.

While pharmaceutical companies argue the price of of drugs reflects what they spend researching and developing new treatments, a study published Monday in JAMA Internal Medicine says the cost of developing a cancer drug is much lower than previously estimated.

While bronze plans tend to be the lowest priced, they also have relatively high out - of - pocket costs when customers go to the doctor, get surgery or buy prescription drugs.

However, there's also a lot of discussion of health care in the press these days, and while a lot of it has to do with pricing, it's also about concerns about the increasing total cost of health care for the ordinary consumer, which is one of the main problems we face in the drug industry.